Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 210, Issue 4, Pages 655-663
Publisher
Rockefeller University Press
Online
2013-03-26
DOI
10.1084/jem.20122824
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
- (2013) Sam Hoot et al. PLoS Pathogens
- HIV vaccine design: the neutralizing antibody conundrum
- (2012) Leonidas Stamatatos CURRENT OPINION IN IMMUNOLOGY
- Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
- (2012) Peter D. Kwong et al. IMMUNITY
- Anti-HIV B Cell Lines as Candidate Vaccine Biosensors
- (2012) T. Ota et al. JOURNAL OF IMMUNOLOGY
- The Development of CD4 Binding Site Antibodies during HIV-1 Infection
- (2012) R. M. Lynch et al. JOURNAL OF VIROLOGY
- Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120
- (2012) Anthony P. West et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01
- (2011) Y. Li et al. JOURNAL OF VIROLOGY
- The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection
- (2011) E. S. Gray et al. JOURNAL OF VIROLOGY
- Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
- (2011) Glenda E Gray et al. LANCET INFECTIOUS DISEASES
- RosettaRemodel: A Generalized Framework for Flexible Backbone Protein Design
- (2011) Po-Ssu Huang et al. PLoS One
- Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
- (2011) X. Wu et al. SCIENCE
- Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
- (2011) R. Diskin et al. SCIENCE
- Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
- (2011) J. F. Scheid et al. SCIENCE
- Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
- (2011) Iliyana Mikell et al. PLoS Pathogens
- The Role of Antibodies in HIV Vaccines
- (2010) John R. Mascola et al. Annual Review of Immunology
- Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
- (2010) T. Zhou et al. SCIENCE
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
- (2010) X. Wu et al. SCIENCE
- Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
- (2009) Xiaodong Xiao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Improving the expression of recombinant soluble HIV Envelope glycoproteins using pseudo-stable transient transfection
- (2009) George Sellhorn et al. VACCINE
- Challenges for structure-based HIV vaccine design
- (2009) William R Schief et al. Current Opinion in HIV and AIDS
- Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection
- (2008) D. N. Sather et al. JOURNAL OF VIROLOGY
- Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C
- (2008) J. M. Binley et al. JOURNAL OF VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started